A. Sorete Arbore (Iasi, Romania), G. Besozzi (Milan, Italy)
Rifampicin- and isoniasid-resistant tuberculosis in penitentiary system of Kyrgyz Republic
J. Isakova, N. Sovhozova, M. Nurbaeva, A. Usupopova, A. Aldashev (Bishkek, Kyrgyzstan)
|   |
The compare of the TB-Biochip oligonucleotide microarray system and bacteriological method for detection of rifampin and isoniazid resistance in mycobacterium tuberculosis
J. Isakova, Z. Goncharova, A. Aldashev (Bishkek, Kyrgyzstan)
| |
Development of real-time PCR technique for detection of the M.tuberculosis DNA mutations associated with fluoroquinolones drug resistance
Y. Alyapkina, M. Vladimirsky, D. Varlamov, J. Alexeev, L. Shipina (Moscow, Russian Federation)
| |
Recurrence after successful treatment of pulmonary tuberculosis (TB) with multidrug-resistance (MDR)
A. Skrahina, A. Astrauko, H. Hurevich, A. Skrahin (Minsk, Belarus)
| |
Intravenous ozon in MDR pulmonary tuberculosis
N. V. Yahorava, H. L. Hurevich, A. M. Skrahina, N. S. Shpakovskay (Minsk, Belarus)
| |
M.tuberculosis strains of W cluster have high capacity to survive within macrophages
S. Andreevskaya, C. Larisa, S. Tatiana, L. Elena, K. Alexey (Moscow, Russian Federation)
| |
Multidrug-resistance TB in Armenia
M. Safaryan, G. Minassian (Yerevan, Armenia)
| |
Risk factors for multidrug-resistant and extensively drug-resistant tuberculosis in Estonia
K. Kliiman, A. Altraja (Tartu, Estonia)
| |
Extensively drug-resistant (XDR) pulmonary tuberculosis in HIV negative cases
B. N. B. M. Prasad, K. Shashirekha, D. Bhattacharyya, N. Grover (New Delhi, India)
| |
The adverse effects of multidrug resistant tuberculosis treatment and relationship with treatment results
D. Duman, T. Karagoz, P. Pazarli, O. Yazicioglu Mocin (Istanbul, Sakarya, Turkey)
| |
Drug resistance profiles of mycobacterium tuberculosis isolates in MDR pulmonary tuberculosis from a high burden developing country
N. A. Rao, I. Muhammad, H. Abbas, M. M. Soomro (Karachi, Pakistan)
| |
Impact of multi-drug-resistant tuberculosis on patients survival in Constanta County
O. Arghir, E. Dantes, G. Voicu, E. Vasiliu, C. Viorica, E. Borgazi (Constanta, Romania)
| |
MDR TB in Azerbaijan, 2006-2007
F. Aghayev, R. Abuzerov, I. Qasimov, S. Rush-Gerdes (Baku, Azerbaijan; Borstel, Germany)
| |
Primary multidrug resistance (PMDR) of mycobacterium tuberculosis (MBT) to antimycobacterial drugs (AMBTD) in the patients with destructive TB.
I. Y. Ossiisky (Vinnitsa, Ukraine)
| |
Prevalence of MDR and XDR tuberculosis among patients with failure of re-treatment course
V. Myasnikov, E. Ivankova (Kiev, Ukraine)
| |
Impact of XDR-TB on treatment outcome of MDR-TB patients with standardized regimens
P. Tabarsi, M. Shamaei, E. Chitsaz, P. Baghaei, M. Kazempour, P. Farnia, D. Mansouri, M. R. Masjedi (Tehran, Islamic Republic Of Iran)
| |
Efficacy and tolerability of linezolid in multidrug-resistant tuberculosis (MDR/XDR-TB)
N. Bevilacqua, G. Gualano, A. Marruchella, D. Biagioli, R. Tonnarini, A. Festa, P. De Mori, E. Bordi, F. Palmieri, F. N. Lauria (Rome, Italy)
| |
Low frequency of drug resistant mycobacterium tuberculosis transmission among close contacts of a highly symptomatic index case
B. Krummel, A. Strassburg, M. Ernst, B. Eker, H. Rath, R. Hoerster, W. Wappler, A. Glaewe, V. Schoellhorn, C. Lange (Borstel, Luebeck, Strassberg, Germany)
| |